KORU Medical Systems (KRMD) Cash from Investing Activities (2010 - 2026)
KORU Medical Systems (KRMD) recorded quarterly Cash from Investing Activities of -$89885.0 in Q1 2026, up 78.68% quarter-over-quarter from -$421655.0 in Q4 2025, and up 79.88% on a YoY basis from -$49968.3 in Q1 2025.
KORU Medical Systems (KRMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
KORU Medical Systems' Cash from Investing Activities history runs 12 years deep, the most recent figure standing at -$89885.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 79.88% year-over-year to -$89885.0; the TTM figure through Mar 2026 stood at -$592837.0 (up 64.0% YoY), while the FY2025 annual figure was -$949790.0, up 28.75% from the prior year.
- Cash from Investing Activities was -$89885.0 for Q1 2026 at KORU Medical Systems, up from -$421655.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $50738.0 in Q4 2024 to a low of -$1.2 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$352287.2 across 5 years, with a median of -$213665.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities sank 1711.48% in 2022, then surged 124.35% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$223872.0 in 2022, then grew by 6.92% to -$208388.0 in 2023, then soared by 124.35% to $50738.0 in 2024, then tumbled by 931.04% to -$421655.0 in 2025, then surged by 78.68% to -$89885.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$89885.0 (Q1 2026), -$421655.0 (Q4 2025), and -$52483.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | KORU Medical Systems | 183.37 Mn | 174.57 Mn | 7.23 Mn | -89,885.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89,885.00 |
| Mar 31, 2026 | -89,885.00 |
| Dec 31, 2025 | -421,655.00 |
| Dec 31, 2025 | -421,655.00 |
| Sep 30, 2025 | -52,483.00 |
| Sep 30, 2025 | -52,483.00 |
| Jun 30, 2025 | -28,814.00 |
| Jun 30, 2025 | -28,814.00 |
| Mar 31, 2025 | -446,838.00 |
| Mar 31, 2025 | -446,838.00 |
| Dec 31, 2024 | 50,738.00 |
| Dec 31, 2024 | 50,738.00 |
| Sep 30, 2024 | -1.10 Mn |
| Sep 30, 2024 | -1.10 Mn |
| Jun 30, 2024 | -148,500.00 |
| Jun 30, 2024 | -148,500.00 |
| Mar 31, 2024 | -133,083.00 |
| Mar 31, 2024 | -133,083.00 |
| Dec 31, 2023 | -208,388.00 |
| Dec 31, 2023 | -208,388.00 |